S&P 500

5.277,51

0,80%

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

Startseite
Investieren
Aktien
USA
NASDAQ
Genaissance Pharmaceuticals (MM) (GNSC)
Genaissance Pharmaceuticals (MM) (GNSC) News

GNSC

Genaissance (GNSC)

Genaissance Pharmaceuticals (MM)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:GNSC

1 2 3 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
03/10/2005	14h00	PR Newswire (US)	Genaissance Enters into HAP(TM) Technology License Agreement with Sankyo	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
21/09/2005	14h00	PR Newswire (US)	Genaissance Enters Pharmacogenomic Collaboration with Otsuka	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
12/09/2005	14h00	PR Newswire (US)	Genaissance Pharmaceuticals and Ipsogen Announce Cancer Biomarker Research Agreements	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
23/08/2005	14h30	PR Newswire (US)	Genaissance Will Provide Genotyping Services for Cyprus Scrapie Contract	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
11/08/2005	14h30	PR Newswire (US)	Genaissance Will Provide Exclusive Genotyping Services for Greek Scrapie Contract	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
18/07/2005	14h30	PR Newswire (US)	Genaissance Pharmaceuticals Enters into HAP(TM) Technology License Agreement with Organon	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
21/06/2005	14h15	PR Newswire (US)	Clinical Data to Acquire Genaissance Pharmaceuticals	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
21/06/2005	13h15	Business Wire	Clinical Data to Acquire Genaissance Pharmaceuticals; Combined Company to Deliver Industry-Defining Theranostics	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
07/06/2005	14h30	PR Newswire (US)	Genaissance to Provide Pharmacogenetic Support to INC Research, Its First CRO Partner	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
03/05/2005	14h30	PR Newswire (US)	Genaissance Reports First Quarter 2005 Results	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
28/04/2005	22h23	PR Newswire (US)	Genaissance Pharmaceuticals Comments on Stock Activity	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
27/04/2005	17h00	PR Newswire (US)	Genaissance Pharmaceuticals to Present at Rodman & Renshaw Techvest 2nd Annual Global Healthcare Conference	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
26/04/2005	17h00	PR Newswire (US)	Genaissance Pharmaceuticals, Inc. Invites You to Participate in its First Quarter 2005 Conference Call	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
22/04/2005	14h31	PR Newswire (US)	Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
22/04/2005	14h30	PR Newswire (US)	Genaissance Pharmaceuticals Obtains $4.5 Million Secured Debt Financing	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
06/04/2005	14h32	PR Newswire (US)	Genaissance and ParAllele BioScience Sign License and Co-Marketing Agreement	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
31/03/2005	18h30	PR Newswire (US)	Genaissance Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
22/03/2005	18h00	PR Newswire (US)	Genaissance Comments on FDA Guidance on Pharmacogenomics	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
11/03/2005	13h30	PR Newswire (US)	Genaissance Allowed Patent for Method of Testing Individuals for Genetic Predisposition to Reduced Metabolism of Drugs	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
09/03/2005	14h00	PR Newswire (US)	Genaissance and Monsanto Company Team Up with the USDA to Map Soybean Genome	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
09/03/2005	14h00	PR Newswire (US)	Genaissance and Monsanto Company Team Up With the USDA to Map Soybean Genome	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
15/02/2005	13h30	PR Newswire (US)	Genaissance Pharmaceuticals' New DNA Test - FAMILION(TM) - Becoming Key Tool for Detecting Long QT Syndrome, a Potentially Fatal	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
10/02/2005	15h00	PR Newswire (US)	Genaissance Pharmaceuticals Reports 2004 Results	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
03/02/2005	16h00	PR Newswire (US)	Genaissance Pharmaceuticals, Inc. Invites You to Participate in its Fourth Quarter 2004 Conference Call	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
26/01/2005	13h30	PR Newswire (US)	Genaissance Obtains License to Vanderbilt Patent Linking Genetics to Key Drug Safety Issue	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
24/01/2005	13h30	PR Newswire (US)	Genaissance Study Sheds Light on Mechanism of Heart Disease Risk by Linking Genetic Variation to the Effect of Hormone Replaceme	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
04/01/2005	13h30	PR Newswire (US)	Genaissance Allowed Patent for Novel Methods to Correlate Genetics With Drug Safety and Efficacy	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
20/12/2004	13h30	PR Newswire (US)	Genaissance Identifies Genetic Markers Implicated in Fatal Side Effects Of Schizophrenia Drug	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
02/12/2004	13h00	PR Newswire (US)	Genaissance Pharmaceuticals Signs Research Agreement With Sygen International	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)
19/11/2004	14h56	PR Newswire (US)	Genaissance to Raise Approximately $6 Million in Private Placement	NASDAQ:GNSC	Genaissance Pharmaceuticals (MM)